The observed CD73 expression levels in the tissue samples are consistent with the findings of the existing literature, which underline CD73’s tendency to be overexpressed in diverse tumors, like melanoma and breast cancer [23,40]. This evidence concerns the gene NT5E and breast carcinoma.